Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELETRIPTAN vs ELIGLUSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELETRIPTAN vs ELIGLUSTAT: Safety Overview

Metric ELETRIPTAN ELIGLUSTAT
Total FAERS Reports 324 1,368
Deaths Reported 20 18
Death Rate 6.2% 1.3%
Hospitalizations 108 173
Average Patient Age 45.1 yrs 48.6 yrs
% Female Patients 82.1% 57.1%
FDA Approval Date N/A Aug 17, 2022
Manufacturer N/A Genzyme Corporation
Route N/A ORAL
Marketing Status N/A Prescription